1040 related articles for article (PubMed ID: 23107709)
1. Empirical, thermodynamic and quantum-chemical investigations of inclusion complexation between flavanones and (2-hydroxypropyl)-cyclodextrins.
Liu B; Li W; Nguyen TA; Zhao J
Food Chem; 2012 Sep; 134(2):926-32. PubMed ID: 23107709
[TBL] [Abstract][Full Text] [Related]
2. An investigation into the supramolecular structure, solubility, stability and antioxidant activity of rutin/cyclodextrin inclusion complex.
Nguyen TA; Liu B; Zhao J; Thomas DS; Hook JM
Food Chem; 2013 Jan; 136(1):186-92. PubMed ID: 23017411
[TBL] [Abstract][Full Text] [Related]
3. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ
Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
[TBL] [Abstract][Full Text] [Related]
4. The inclusion complexes of hesperetin and its 7-rhamnoglucoside with (2-hydroxypropyl)-beta-cyclodextrin.
Tommasini S; Calabrò ML; Stancanelli R; Donato P; Costa C; Catania S; Villari V; Ficarra P; Ficarra R
J Pharm Biomed Anal; 2005 Sep; 39(3-4):572-80. PubMed ID: 15985355
[TBL] [Abstract][Full Text] [Related]
5. Aggregation of cyclodextrins as an important factor to determine their complexation behavior.
Bikádi Z; Kurdi R; Balogh S; Szemán J; Hazai E
Chem Biodivers; 2006 Nov; 3(11):1266-78. PubMed ID: 17193241
[TBL] [Abstract][Full Text] [Related]
6. Preparation, characterization and in vivo evaluation of formulation of baicalein with hydroxypropyl-beta-cyclodextrin.
Liu J; Qiu L; Gao J; Jin Y
Int J Pharm; 2006 Apr; 312(1-2):137-43. PubMed ID: 16459034
[TBL] [Abstract][Full Text] [Related]
7. Formation of natamycin:cyclodextrin inclusion complexes and their characterization.
Koontz JL; Marcy JE
J Agric Food Chem; 2003 Nov; 51(24):7106-10. PubMed ID: 14611179
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the 13-cis-retinoic acid/cyclodextrin inclusion complexes by phase solubility, photostability, physicochemical and computational analysis.
Yap KL; Liu X; Thenmozhiyal JC; Ho PC
Eur J Pharm Sci; 2005 May; 25(1):49-56. PubMed ID: 15854800
[TBL] [Abstract][Full Text] [Related]
9. Inclusion complexes of fluorofenidone with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin.
Wang S; Ding Y; Yao Y
Drug Dev Ind Pharm; 2009 Jul; 35(7):808-13. PubMed ID: 19337873
[TBL] [Abstract][Full Text] [Related]
10. Study on the complexation of isoquercitrin with beta-cyclodextrin and its derivatives by spectroscopy.
Wang Y; Qiao X; Li W; Zhou Y; Jiao Y; Yang C; Dong C; Inoue Y; Shuang S
Anal Chim Acta; 2009 Sep; 650(1):124-30. PubMed ID: 19720183
[TBL] [Abstract][Full Text] [Related]
11. Preparation and characterization of inclusion complexes formed between baicalein and cyclodextrins.
Zhou Q; Wei X; Dou W; Chou G; Wang Z
Carbohydr Polym; 2013 Jun; 95(2):733-9. PubMed ID: 23648035
[TBL] [Abstract][Full Text] [Related]
12. Enhanced stability of a naringenin/2,6-dimethyl β-cyclodextrin inclusion complex: molecular dynamics and free energy calculations based on MM- and QM-PBSA/GBSA.
Sangpheak W; Khuntawee W; Wolschann P; Pongsawasdi P; Rungrotmongkol T
J Mol Graph Model; 2014 May; 50():10-5. PubMed ID: 24681901
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the complexation between methylprednisolone and different cyclodextrins in solution by 1H-NMR and molecular modeling studies.
Thi TD; Nauwelaerts K; Froeyen M; Baudemprez L; Van Speybroeck M; Augustijns P; Annaert P; Martens J; Van Humbeeck J; Van den Mooter G
J Pharm Sci; 2010 Sep; 99(9):3863-73. PubMed ID: 20665846
[TBL] [Abstract][Full Text] [Related]
14. Temperature-controlled poly(propylene) glycol hydrophobicity on the formation of inclusion complexes with modified cyclodextrins. A DSC and ITC study.
De Lisi R; Lazzara G; Milioto S
Phys Chem Chem Phys; 2011 Jul; 13(27):12571-7. PubMed ID: 21666930
[TBL] [Abstract][Full Text] [Related]
15. Studying on inclusion complexes of Wogonin with β-cyclodextrin and hydroxypropyl-cyclodextrin.
Li J; Chao J; Zhang M
Spectrochim Acta A Mol Biomol Spectrosc; 2012 Feb; 87():25-8. PubMed ID: 22192416
[TBL] [Abstract][Full Text] [Related]
16. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
Badr-Eldin SM; Elkheshen SA; Ghorab MM
Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
[TBL] [Abstract][Full Text] [Related]
17. Curve-fitting FTIR studies of loratadine/hydroxypropyl-beta-cyclodextrin inclusion complex induced by co-grinding process.
Lin SY; Hsu CH; Sheu MT
J Pharm Biomed Anal; 2010 Nov; 53(3):799-803. PubMed ID: 20619996
[TBL] [Abstract][Full Text] [Related]
18. [Dissolution of nimodipine in an aqueous solution of hydroxyethyl-beta-cyclodextrin and a review of solubility of nimodipine with cyclodextrins].
Kopecký F; Kopecká B; Kaclík P
Ceska Slov Farm; 2003 Jan; 52(1):33-8. PubMed ID: 12685332
[TBL] [Abstract][Full Text] [Related]
19. Inclusion complexes of quercetin with three β-cyclodextrins derivatives at physiological pH: spectroscopic study and antioxidant activity.
Liu M; Dong L; Chen A; Zheng Y; Sun D; Wang X; Wang B
Spectrochim Acta A Mol Biomol Spectrosc; 2013 Nov; 115():854-60. PubMed ID: 23892509
[TBL] [Abstract][Full Text] [Related]
20. [Solubilization and complexation of the antileukotrienic drug Quinlukast in aqueous solutions of cyclodextrins].
Kopecký F; Kopecká B
Ceska Slov Farm; 2005 May; 54(3):137-40. PubMed ID: 15945461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
